Life Sciences & Medicine

  • AB25 2ZD

Impacts

Aberdeen research prompts change in dental policy benefiting thousands of Scottish children

Craig Robert Ramsay (Coordinator), Jeremy M Grimshaw (Coordinator), Graeme Stewart MacLennan (Coordinator), Jan Clarkson (Coordinator), Nigel B. Pitts (Coordinator), Ruth Elizabeth Thomas (Coordinator), Elizabeth A Shirran (Coordinator), Marion Kay Campbell (Coordinator), Jill Ann Mollison (Coordinator)

Impact

Assessment of Mood and Cognitive Function

John Robertson Crawford (Coordinator), Paul H. Garthwaite (Coordinator), David C. Howell (Coordinator)

Impact

Cannabis as a source of medicines

Roger Pertwee (Coordinator), P Consroe (Coordinator), R Musty (Coordinator), David Baker (Coordinator)

Impact: Quality of life Impacts

Carbon-calculating: the development of Scottish Windfarms

Joanne Ursula Smith (Coordinator), Pete Smith (Coordinator), Dali Rani Nayak (Coordinator)

Impact: Quality of life Impacts

Commercial applications of pioneering research on the human gut microbiota

Karen Patricia Scott (Participant), Petra Gisela Helen Louis (Participant), Alan Walker (Participant), Sylvia Helen Duncan (Participant), Harry James Flint (Participant)

Impact: Economic Impacts, Quality of life Impacts

Depressive Disorder Research

Ian Reid (Coordinator), Isobel Mary Cameron (Coordinator), Kenneth Lawton (Coordinator), John Robertson Crawford (Coordinator)

Impact

Development of an international standard measure for the reporting of patients’ assessment of their varicose veins

Andrew Garratt (Coordinator), D. Ruta (Coordinator), K Buckingham (Coordinator), Zygmunt Krukowski (Coordinator)

Impact

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

Claude Michel Wischik (Participant), Charles Robert Harrington (Participant), John Mervyn David Storey (Participant), Janet Elizabeth Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven John Kemp (Participant), James Peter Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant), C Marshall (Participant)

Impact: Quality of life Impacts, Economic Impacts

Discovery and commercialisation of new drug for rheumatoid arthritis and related conditions

Iain Robert Greig (Coordinator), Stuart Ralston (Coordinator), Rob. J. van't Hof (Coordinator)

Impact

Discovery of rice as the major dietary source of inorganic arsenic

Andrew Alexander Meharg (Coordinator)

Impact: Public policy Impacts

From melatonin receptors to Valdoxan

Peter John Morgan (Coordinator), Lynda Williams (Coordinator), Perry Barrett (Coordinator), A D Strosberg (Coordinator)

Impact: Quality of life Impacts

Impacts of offshore energy developments

Paul Michael Thompson (Coordinator), Philip S. Hammond (Coordinator), David Lusseau (Coordinator), D L Borchers (Coordinator), Gordon Hastie (Coordinator)

Impact: Quality of life Impacts

Improved public health through the impact of research underpinning the introduction of Smokefree Legislation in Scotland

Anne Ludbrook (Coordinator), Edwin Roland Van Teijlingen (Coordinator), Sheona Anne Bird (Coordinator)

Impact

Influencing national and international breastfeeding care through the generation of high quality evidence

Pat Hoddinott (Coordinator), David John Godden (Coordinator), Rosemary Jane Britten (Coordinator), Jill Ann Mollison (Coordinator), Amanda Jane Lee (Coordinator), Gordon Prescott (Coordinator), Anne Ludbrook (Coordinator)

Impact

Inorganic arsenic in rice bran and its products are an order of magnitude

Pete Smith (Coordinator), Jon Hillier (Coordinator), Joanne Ursula Smith (Coordinator)

Impact: Quality of life Impacts

Making surgery safer: non-technical skills of anaesthetists, surgeons and scrub nurses

Rhona Flin (Coordinator), Georgina Claudia Fletcher (Coordinator), Steven Yule (Coordinator), Lucy Mitchell (Coordinator)

Impact

Management of Change in the Healthcare Sector

Lorna McKee (Coordinator), Patrick C. Flood (Coordinator)

Impact: Social Impacts